Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-125294
Filing Date
2024-11-12
Accepted
2024-11-12 16:00:26
Documents
75
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q clym-20240930.htm   iXBRL 10-Q 2429370
2 EX-3.1 clym-ex3_1.htm EX-3.1 73354
3 EX-10.1 clym-ex10_1.htm EX-10.1 84373
4 EX-10.2 clym-ex10_2.htm EX-10.2 11446
5 EX-31.1 clym-ex31_1.htm EX-31.1 16618
6 EX-31.2 clym-ex31_2.htm EX-31.2 16075
7 EX-32.1 clym-ex32_1.htm EX-32.1 9864
8 EX-32.2 clym-ex32_2.htm EX-32.2 9322
9 GRAPHIC img208541110_0.jpg GRAPHIC 112614
10 GRAPHIC img208541110_1.jpg GRAPHIC 118292
11 GRAPHIC img208541110_2.jpg GRAPHIC 56190
  Complete submission text file 0000950170-24-125294.txt   10143059

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT clym-20240930.xsd EX-101.SCH 1315559
77 EXTRACTED XBRL INSTANCE DOCUMENT clym-20240930_htm.xml XML 1593474
Mailing Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481
Business Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481 1-866-857-2596
Climb Bio, Inc. (Filer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40708 | Film No.: 241447711
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)